Washington: India’s Ambassador to the US Taranjit Singh Sandhu said that Ayurvedic doctors and researchers in India and the US are planning to start a joint clinical trial of Ayurvedic medicines to protect against the coronavirus.
In a digital dialogue with a group of eminent Indian-American scientists, scholars and doctors on Wednesday, Sandhu said that a wide network of institutional participation has brought the scientific communities of the two countries together in the fight against Covid-19. He said that our institutes have come together to promote Ayurveda through joint research, teaching and training programs.
Ayurvedic doctors and researchers from both countries are planning to start a joint clinical trial of Ayurvedic medicines to protect against Covid-19. In this sequence, he further said that our scientists are exchanging knowledge and research resources on this front.
Sandhu said that Indian pharmaceutical companies are pioneers in making affordable medicines and vaccines and will play an important role in the fight against this epidemic. According to the ambassador, there are at least three partnerships of Indian pharmaceutical companies with US-based institutions. He said that this will not only benefit India and the US but will also benefit billions of people around the world who need vaccines to protect against Covid-19.